Biologics
Total Trials
31
As Lead Sponsor
29
As Collaborator
2
Total Enrollment
2,692
NCT01233349
Safety and Efficacy of Litramine in Overweight and Obese Subjects
Phase: Phase 3
Role: Lead Sponsor
Start: Jul 31, 2010
Completion: Jan 31, 2011
NCT01407393
Safety and Efficacy of Glucosanol in Reducing Body Weight in Overweight and Obese Subjects
Phase: Phase 4
Start: May 31, 2011
Completion: Dec 31, 2011
NCT01423617
Efficacy and Safety of Zenoctil in Reducing Body Weight
Start: Jul 31, 2011
NCT01435278
Efficacy and Safety of Glucosanol in Maintaining Body Weight
Start: Sep 30, 2011
Completion: Jul 31, 2012
NCT01503957
Nasya in Allergic Rhinitis
Start: Jan 31, 2012
Completion: Sep 30, 2012
NCT01505387
Litramine in Weight Maintenance
NCT01590667
Effect of Litramine on Fat Excretion
Start: May 31, 2012
NCT02488356
Litramine for Weight Loss
Phase: N/A
Start: Sep 30, 2012
Completion: May 31, 2013
NCT01681069
Efficacy and Safety of IQP-VV-102 in Weight Management
Start: Oct 31, 2012
Completion: Jun 30, 2013
NCT01718639
Safety and Efficacy of IQP-LH-101 in Postprandial Heartburn
Completion: Mar 31, 2013
NCT01774825
IQP-CL-101 in IBS Management
Start: Jan 31, 2013
Completion: Feb 28, 2014
NCT01809587
IQP-PO-101 for the Regulation of Bowel Movement Frequency
Start: Mar 31, 2013
Completion: Aug 31, 2013
NCT01905956
Safety and Efficacy of IQP- AK-102 in Reducing Body Weight
Start: Jul 31, 2013
Completion: Jul 31, 2014
NCT01964885
Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections
Start: Oct 31, 2013
Completion: May 31, 2014
NCT01969214
Safety and Efficacy of IQP-MM-101 in Reducing Symptoms of Diarrhoea
NCT02041754
Safety and Efficacy of IQP-AK-102 in Reducing Appetite
Start: Jan 31, 2014
Completion: Aug 31, 2014
NCT02541344
Benefit of IQP-VV-102 in Reducing Postprandial Glucose Level in Overweight Caucasian Subjects
Start: Jun 30, 2014
Completion: Not specified
NCT02547818
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Role: Collaborator
Start: Sep 15, 2015
Completion: Nov 18, 2020
NCT02774486
Efficacy and Safety of IQP-AK-102 in Reducing Appetite
Start: May 1, 2016
Completion: Jul 20, 2016
NCT02930668
Efficacy and Safety of Glucosanol™ in Body Weight Reduction
Start: May 31, 2016
Completion: Nov 30, 2016
NCT02873910
Influence of IQPAS-119 on Post-Marathon Susceptibility to Infections and Others
Start: Jul 10, 2016
Completion: Oct 31, 2016
NCT02930681
Efficacy of Glucosanol™ in Reducing Post-prandial Glucose Levels in Overweight Subjects
Start: Aug 31, 2016
NCT02871271
Tolerability and Benefit of IQP-AS-121 on Fatigue and Mental Alertness
Start: Nov 30, 2016
Completion: Sep 30, 2017
NCT02871362
Benefit of IQP-AS-118 on Blood Pressure and LDL-cholesterol
Start: Mar 17, 2017
Completion: Jan 30, 2018
NCT03114696
Benefit of IQP-AO-101 for Sleep
Start: Apr 25, 2017
Completion: Sep 29, 2017
NCT03058367
Benefit and Tolerability of IQP-AE-103 in Weight Loss
Start: May 1, 2017
Completion: Nov 28, 2017
NCT03227276
Efficacy and Safety of Litramine in 1 Year Weight Loss Study
Start: Aug 14, 2017
Completion: Feb 19, 2020
NCT03232255
Clinical Benefit of a Mouthrinse for the Treatment of Dentine Hypersensitivity
Start: Aug 25, 2017
Completion: Dec 7, 2017
NCT02871310
Vasoactive Effects of IQP-AS-118 in Healthy Individuals
Start: Mar 31, 2018
Completion: Dec 31, 2018
NCT03888911
Benefit and Tolerability of IQP-LU-104 in Weight Loss
Start: Mar 5, 2019
Completion: Nov 21, 2019
NCT05757154
Coffee for Optimal Metabolite Profile
Start: Mar 31, 2023
Completion: Jul 3, 2023
Loading map...